ClinConnect ClinConnect Logo
Search / Trial NCT05706493

Association Between Periodontitis and the Level of Anti-citrullinated Protein Antibodies in Rheumatoid Arthritis

Launched by MISR INTERNATIONAL UNIVERSITY · Jan 23, 2023

Trial Information

Current as of April 25, 2025

Completed

Keywords

Periodontitis Rheumatoid Arthritis Anti Citrullinated Protein Antibodies Peptidyl Arginine Deminase Enzyme Gingival Crevicular Fluid (Gcf)

ClinConnect Summary

This clinical trial is looking at how gum disease, known as periodontal disease, relates to rheumatoid arthritis (RA). Researchers want to see if there’s a connection between certain antibodies in the mouth and the severity of both gum disease and rheumatoid arthritis in patients who have RA. By studying the fluid from the gums before and after a non-surgical treatment for gum disease, the trial aims to understand better how these two conditions affect each other.

To participate in this study, you need to be at least 18 years old and have been diagnosed with rheumatoid arthritis. You should have at least 8 teeth and meet specific criteria related to your RA. However, if you smoke, have diabetes, are pregnant, have had recent gum treatment, or are taking antibiotics, you won't be eligible to join. If you do participate, you can expect to undergo a non-surgical treatment for your gum disease and provide samples for testing. This research could help improve our understanding of how to manage both conditions better.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Rheumatoid patients fulfilling the ACR criteria for the classification of RA
  • 18 years
  • Both genders
  • Presence of at least 8 teeth
  • Exclusion Criteria:
  • Smoking
  • Diabetes Mellitus
  • Pregnant females
  • Patients who had undergone periodontal treatment within last 3 months
  • Antibiotic therapy during last 3 months
  • Other autoimmune diseases

Trial Officials

Zainab Hafez, Lecturer

Principal Investigator

Lecturer, faculty of oral and dental medicine misr international university

Yahia Hassan, Lecturer

Principal Investigator

Lecturer, faculty of oral and dental medicine misr international university

Shahinaz Al ashiry, asso.Prof

Study Director

Associate Professor, faculty of oral and dental medicine misr international universit

About Misr International University

MISR International University is a distinguished educational institution dedicated to advancing health sciences and clinical research. As a clinical trial sponsor, the university emphasizes innovative methodologies and rigorous scientific standards to enhance the quality of healthcare solutions. Committed to fostering collaboration between academia and industry, MISR International University actively engages in clinical trials that aim to address pressing medical challenges while ensuring ethical practices and patient safety. Through its comprehensive approach, the university seeks to contribute significantly to the body of clinical knowledge and improve health outcomes in the community.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials